Initial BC molecular classification was introduced by Perou et Sørlie [13] at the beginning of the millennium, and this enabled BC tumour classification into Luminal, HER2 positive, basal and ‘normal-like’ subtypes through differences in gene expression pattern. Here, ERBB2 is linked to breast cancer.